Real-world clinical outcomes and economic burden of early discontinuation of taxane therapy among patients with metastatic castration-resistant prostate cancer

被引：0
|
作者：
Patel, Jeetvan
Nguyen, Jennifer
Bollu, Vamsi
Kang, Barinder
Sawhney, Amrita
Byrne, Clare
Tang, Jackson
Gorritz, Magdaliz
Chen, Chi-Chang
Shore, Neal D.
机构：
[1] Novartis Pharmaceut, E Hanover, NJ USA
[2] Asclepius Analyt, New York, NY USA
[3] IQVIA Inc, King Of Prussia, PA USA
[4] Carolina Urol Res Ctr, Myrtle Beach, SC USA
[5] GenesisCare US, Myrtle Beach, SC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17043
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Beyond Frontline Therapy with Abiraterone and Enzalutamide in Metastatic Castration-Resistant Prostate Cancer: A Real-World US Study
    Shore, Neal D.
    Ionescu-Ittu, Raluca
    Laliberte, Francois
    Yang, Lingfeng
    Lejeune, Dominique
    Yu, Louise
    Duh, Mei Sheng
    Mahendran, Malena
    Kim, Jeri
    Ghate, Sameer R.
    CLINICAL GENITOURINARY CANCER, 2021, 19 (06) : 480 - 490
  • [32] Real-world evidence of patients with metastatic castration-resistant prostate cancer treated with cabazitaxel: comparison with the randomized clinical study CARD
    Ronald de Wit
    Stephen J. Freedland
    Stephane Oudard
    Georgi Marinov
    Philippe Capart
    Austin J. Combest
    Ryan Peterson
    Ayse Ozatilgan
    Alicia K. Morgans
    Prostate Cancer and Prostatic Diseases, 2023, 26 : 67 - 73
  • [33] Outcomes of First Subsequent Taxane Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer Who Previously Received Docetaxel Intensification for Metastatic Castration-Sensitive Prostate Cancer
    Robin, Gabrielle
    Basappa, Naveen S.
    North, Scott
    Ghosh, Sunita
    Kolinsky, Michael
    CURRENT ONCOLOGY, 2024, 31 (09) : 5080 - 5087
  • [34] Real-world evidence of patients with metastatic castration-resistant prostate cancer treated with cabazitaxel: comparison with the randomized clinical study CARD
    de Wit, Ronald
    Freedland, Stephen J.
    Oudard, Stephane
    Marinov, Georgi
    Capart, Philippe
    Combest, Austin J.
    Peterson, Ryan
    Ozatilgan, Ayse
    Morgans, Alicia K.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2023, 26 (01) : 67 - 73
  • [35] Real-world outcomes in first-line treatment of metastatic castration-resistant prostate cancer (mCRPC): The prostate cancer registry.
    Chowdhury, Simon
    Birtle, Alison J.
    Bjartell, Anders
    Costa, Luis
    Feyerabend, Susan
    Galli, Luca
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [36] Edmonton Prostate Interdisciplinary Cancer Clinic (EPICC): Real-world efficacy outcomes of a multidisciplinary clinic for metastatic castration-resistant prostate cancer
    Follett, Graeme
    Tilley, Derek
    Basappa, Naveen S.
    Danielson, Brita Lavender
    Chetner, Michael
    Kolinsky, Michael Paul
    North, Scott A.
    Rayner-Myers, Sarah
    Todd, Gerry
    Fairey, Adrian S.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [37] Real-world outcomes in second-line treatment of metastatic castration-resistant prostate cancer (mCRPC): The Prostate Cancer Registry.
    Chowdhury, Simon
    Birtle, Alison J.
    Bjartell, Anders
    Costa, Luis
    Feyerabend, Susan
    Galli, Luca
    Kalinka-Warzocha, Ewa
    Kramer, Gero
    Lumen, Nicolaas
    Maroto, Pablo
    Matveev, Vsevolod B.
    Paiss, Thomas
    Pisconti, Salvatore
    Spaeth, Dominique
    Veiga, Francisco Gomez
    Antoni, Laurent
    Klumper, Edwin
    Wapenaar, Robert
    van den Berg, Erik
    Lee, Emma
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [38] Efficacy of abiraterone acetate in castration-resistant metastatic prostate cancer: A real-world data analysis
    Oyman, Abdilkerim
    Basak, Mustafa
    Ozcelik, Melike
    Ozyukseler, Deniz Tataroglu
    Isik, Selver
    Yildirim, Mahmut Emre
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 (05) : E201 - E207
  • [39] STATINS AND ORAL TREATMENTS IN PATIENTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC): REAL-WORLD OUTCOMES
    Engel-Nitz, Nicole
    Behl, Ajay
    Blauer-Peterson, Cori
    Dawson, Nancy
    JOURNAL OF UROLOGY, 2017, 197 (04): : E675 - E675
  • [40] Real-world treatment and clinical outcomes in metastatic castration-resistant prostate cancer (mCRPC): REMPRO-Middle East and Africa (MEA)
    El Husseiny, G.
    Nowier, A.
    Basulaiman, B.
    Ghali, R.
    Farag, H.
    Aboutaleb, A.
    Rajadhyaksha, V.
    Tirmazy, S. H.
    Sahin, B.
    ANNALS OF ONCOLOGY, 2024, 35
12345